PLATELET THROMBIN RECEPTOR

Information

  • Research Project
  • 3501738
  • ApplicationId
    3501738
  • Core Project Number
    R43HL044251
  • Full Project Number
    1R43HL044251-01
  • Serial Number
    44251
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/15/1990 - 34 years ago
  • Project End Date
    9/14/1990 - 34 years ago
  • Program Officer Name
  • Budget Start Date
    3/15/1990 - 34 years ago
  • Budget End Date
    9/14/1990 - 34 years ago
  • Fiscal Year
    1990
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/6/1990 - 34 years ago
Organizations

PLATELET THROMBIN RECEPTOR

This is a request for Phase I funding to test the hypothesis that glycoprotein (GP) V is the thrombin receptor on platelets. Recent data indicate that thrombin, acting proteolytically at a receptor on the platelet surface, is the physiologically important agonist to activate platelets and to initiate arterial thrombus formation. Previous studies from the applicant's laboratory have shown that the only detectable thrombin substrate on the platelet membrane surface is GP V. In the proposed study, GP V will be cloned to deduce the amino acid sequence of this protein.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    HEM
  • Study Section Name
    Hematology Subcommittee 2
  • Organization Name
    COR THERAPEUTICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SOUTH SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94080
  • Organization District
    UNITED STATES